Intermittent tetracosactrin-depot therapy in dermatology.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000009:adverse effects; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003874:Dermatitis Herpetiformis / Q000188:drug therapy; D003873:Dermatitis, Exfoliative / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008548:Melanosis / Q000139:chemically induced; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy; D010455:Peptides / Q000008:administration & dosage; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D010455:Peptides; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone